← Back to Search

Tab-G for Arthritis

N/A

Waitlist Available

Led By Jeungok Choi, PhD

Research Sponsored by University of Massachusetts, Amherst

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 24 hours

Awards & highlights

Study Summary

This trial will test a tablet-based cognitive behavioral group education intervention for long-term effects on daily steps, fatigue levels, self-efficacy, and quality of life.

Eligible Conditions

Arthritis
Fatigue

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 24 hours

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~24 hours

This trial's timeline: 3 weeks for screening, Varies for treatment, and 24 hours for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

BRICS NINR PROMIS Fatigue Short Form 6a

Quality of Life-Rheumatoid Arthritis Scale

Self-Efficacy for Managing Chronic Disease 6-Item Scale

+1 more

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Tab-G (tablet-based group CBT education)Experimental Treatment1 Intervention

Tab-G participants will receive 4 weekly CBT(cognitive behavioral therapy)-based group learning sessions to encourage a simple walking activity through videoconferencing meetings in a group of 5 members. The educational materials emphasize shared goal setting and mutual reinforcement.

Group II: Usual care groupActive Control1 Intervention

A usual care group will receive general arthritis management education. Participant are instructed to maintain usual activity during the study period.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Tab-G

2021

N/A

~40

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of Massachusetts, AmherstLead Sponsor

78 Previous Clinical Trials

467,732 Total Patients Enrolled

1 Trials studying Arthritis

24 Patients Enrolled for Arthritis

Jeungok Choi, PhDPrincipal Investigator - University of Massachusetts, Amherst

University of Massachusetts, Amherst

1 Previous Clinical Trials

24 Total Patients Enrolled

1 Trials studying Arthritis

24 Patients Enrolled for Arthritis

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are participants being recruited for this experiment currently?

"Affirmative, clinicaltrials.gov data reveals that this medical trial is attempting to acquire candidates. The experiment was uploaded on January 21st 2021 and most recently modified on April 21st 2022. 40 participants must be recruited from one research facility."

Answered by AI

What is the current enrollment size of this clinical trial?

"Affirmative. Clinicaltrials.gov documents that this clinical trial is currently accepting participants; the study was first posted on January 21st 2021, and last updated April 21st 2022. 40 patients will be chosen from one medical centre to partake in the investigation."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Tablet-based Cognitive Behavioral Intervention for Older Adults With Arthritis Fatigue

Jeungok Choi 2021. "Tablet-based Cognitive Behavioral Intervention for Older Adults With Arthritis Fatigue". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04792853.